Many, if not most, small and midsized biopharma companies opt to partner with outside vendors—contract development and manufacturing organization, or CDMOs—to handle their end-to-end biologic development and manufacturing.
CDMOs are valuable for small, entrepreneurial companies that have innovative ideas and promising molecules, but don’t always have the in-house expertise or capacity required to fully develop a product, but many larger biopharma companies choose to work with CDMOs as well. They're leveraged to advance multiple programs simultaneously or to mitigate risk by establishing secondary sourcing for their key biologic products.
As a drug sponsor, CDMOs can offer you a wealth of expertise and services. But how do you choose the right company? What should you look for, and what questions should you ask? In our new playbook, we highlight:
Thank you for your interest in the playbook! Click below to get your copy.Download Now
Enter the 6 digit code sent to your mobile number
Click on Resend the verification code again